Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-24 Purchase | 2022-06-28 7:15 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 10,000 | $1.0134 | $10,135 | 1,385,119 (Indirect Direct) | View |
| 2022-06-02 Purchase | 2022-06-06 6:43 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 5,890 | $0.98424 | $5,797 | 1,375,119 (Indirect Direct) | View |
| 2022-03-31 Purchase | 2022-04-01 4:18 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 15,000 | $1.6356 | $24,534 | 1,369,229 (Indirect Direct) | View |
| 2022-03-16 Purchase | 2022-03-17 7:10 pm | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 49,038 | $1.5711 | $77,045 | 248,444 (Indirect) | View |
| 2022-03-15 Purchase | 2022-03-17 7:09 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 30,000 | $1.4867 | $44,600 | 1,354,229 (Indirect Direct) | View |
| 2021-09-30 Sale | 2021-10-01 7:39 pm | Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner | 5,000,000 | $5.012 | $25,059,900 | 81,077 (Indirect) | View |
| 2021-09-20 Sale | 2021-09-22 5:27 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 1,109,644 | $6.09 | $6,757,732 | 6,943,654 (Indirect) | View |
| 2021-09-20 Sale | 2021-09-22 5:24 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 1,109,644 | $6.09 | $6,757,732 | 6,943,654 (Indirect) | View |
| 2021-08-20 Purchase | 2021-08-23 9:01 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 10,000 | $1.9254 | $19,254 | 1,324,229 (Indirect Direct) | View |
| 2021-05-04 Purchase | 2021-05-05 5:01 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 35,714 | $2.8 | $99,999 | 1,314,229 (Indirect Direct) | View |
| 2021-02-17 Purchase | 2021-02-19 4:52 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 1,285,714 | $3.5 | $4,499,999 | 8,053,298 (Indirect) | View |
| 2021-02-17 Purchase | 2021-02-19 4:47 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 1,285,714 | $3.5 | $4,499,999 | 8,053,298 (Indirect) | View |
| 2021-02-17 Purchase | 2021-02-17 4:44 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 100,000 | $3.5 | $350,000 | 1,278,515 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-15 Option Award | 2022-06-17 9:31 pm | N/A 2032-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 9:27 pm | N/A 2032-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:37 pm | N/A 2032-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 3,290,616 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:35 pm | N/A 2032-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 6,958,654 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:26 pm | N/A 2032-06-15 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:26 pm | N/A 2032-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-09-22 Ownership | 2021-09-22 3:30 pm | N/A N/A | Corvus Pharmaceuticals Inc. | CRVS | EcoR1 Capital LLC 10% Owner | 0 | $0 | 5,081,077 (Indirect) | View |
| 2021-09-09 Option Award | 2021-09-13 5:00 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 320,000 | $0 | 320,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:59 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:57 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:56 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:55 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:53 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 3,290,616 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:53 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 8,068,298 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:51 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:48 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:02 pm | N/A 2021-09-09 | Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner | 15,000 | $0 | 3,290,616 (Indirect) | View |
| 2021-06-15 Option Award | 2021-06-16 4:19 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:19 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:18 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:17 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:16 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 3,290,616 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:15 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 8,068,298 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:15 pm | N/A 2031-06-15 | Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner | 15,000 | $0 | 3,290,616 (Indirect) | View |
| 2020-12-16 Option Award | 2020-12-17 4:17 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 160,000 | $0 | 160,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-17 4:17 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 160,000 | $0 | 160,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-17 4:16 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 320,000 | $0 | 320,000 (Direct) | View |